|

Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC1

Indications

  • Liver Disease1
  • Liver Steatoses1
  • Liver Transplant Rejection1
  • Liver Failure1
  • Liver Metastases1

Other1 trial

CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.